Department of Anesthesiology, Intensive Care and Reanimation, AZ Sint Jan Brugge-Oostende, Ruddershove 10, B-8000, Brugge, Belgium.
Department of Anesthesiology, KU Leuven - University of Leuven, B-3000, Leuven, Belgium.
Obes Surg. 2019 Jun;29(6):1841-1850. doi: 10.1007/s11695-019-03763-1.
Deep neuromuscular block (NMB) and opioid-free anaesthesia (OFA) improve surgical workspace and reduce post-operative opioid consumption, but its impact on perioperative outcomes is unknown. This observational study compared complications and healthcare resource utilization after bariatric surgery, with or without continuous deep NMB or OFA.
We included all 9246 patients who underwent laparoscopic bariatric surgery at our institution from January 2009 to February 2017. Continuous clinical deep NMB was defined as receiving a continuous infusion of rocuronium with a dose of > 1 mg/kg IBW for each hour or sugammadex > 2 mg/kg total body weight at the time of reversal. We analysed the effect of continuous clinical deep NMB and OFA and covariates on 1 month post-operative complications using the Clavien-Dindo (CD) classification (grades II-V) and healthcare utilization (hospital length of stay [LOS], rates of reoperations within 1 week, high-dependency care unit admissions, and readmissions within 1 month). Covariates included experience of the attending anaesthesiologist, patient age, sex, body mass index, American Society of Anesthesiologists physical status score, obstructive sleep apnoea syndrome, diabetes, hypertension, surgery type, surgical team experience, and neostigmine use.
OFA, continuous deep NMB, surgical and anaesthesia team experience, younger age, and surgery type were associated with fewer complications. OFA was associated with lower healthcare resource utilization. Reduced LOS was also associated with younger age, surgical team experience, and surgery type, but not continuous deep NMB.
Continuous deep NMB and OFA were associated with fewer complications after bariatric surgery.
深度神经肌肉阻滞(NMB)和无阿片类麻醉(OFA)可改善手术空间并减少术后阿片类药物的消耗,但对围手术期结果的影响尚不清楚。本观察性研究比较了接受或不接受持续深度 NMB 或 OFA 的肥胖症手术患者的并发症和医疗资源利用情况。
我们纳入了 2009 年 1 月至 2017 年 2 月期间在我院接受腹腔镜减肥手术的所有 9246 例患者。连续临床深度 NMB 的定义为在逆转时每小时接受> 1mg/kg IBW 的罗库溴铵持续输注或> 2mg/kg 总体重的琥珀酸舒更葡糖钠。我们使用 Clavien-Dindo(CD)分类(等级 II-V)和医疗保健利用(住院时间[LOS]、1 周内再次手术率、高度依赖护理病房入院率和 1 个月内再入院率)分析连续临床深度 NMB 和 OFA 及协变量对术后 1 个月并发症的影响。协变量包括主治麻醉师的经验、患者年龄、性别、体重指数、美国麻醉医师协会身体状况评分、阻塞性睡眠呼吸暂停综合征、糖尿病、高血压、手术类型、手术团队经验和新斯的明使用情况。
OFA、持续深度 NMB、手术和麻醉团队经验、年龄较小以及手术类型与并发症较少相关。OFA 与较低的医疗资源利用率相关。较短的 LOS 也与年龄较小、手术团队经验和手术类型相关,但与持续深度 NMB 无关。
肥胖症手术后,持续深度 NMB 和 OFA 与并发症减少相关。